Compare Divis Laboratories with GUFIC BIOSCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs GUFIC BIOSCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES GUFIC BIOSCIENCE DIVIS LABORATORIES/
GUFIC BIOSCIENCE
 
P/E (TTM) x 59.1 22.7 260.2% View Chart
P/BV x 13.6 10.6 128.7% View Chart
Dividend Yield % 0.4 0.1 794.0%  

Financials

 DIVIS LABORATORIES   GUFIC BIOSCIENCE
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-21
GUFIC BIOSCIENCE
Mar-21
DIVIS LABORATORIES/
GUFIC BIOSCIENCE
5-Yr Chart
Click to enlarge
High Rs3,913137 2,847.9%   
Low Rs1,82445 4,071.8%   
Sales per share (Unadj.) Rs262.550.3 521.8%  
Earnings per share (Unadj.) Rs74.74.6 1,638.2%  
Cash flow per share (Unadj.) Rs84.46.2 1,351.1%  
Dividends per share (Unadj.) Rs20.000.10 20,000.0%  
Avg Dividend yield %0.70.1 635.2%  
Book value per share (Unadj.) Rs350.117.9 1,956.9%  
Shares outstanding (eoy) m265.4796.94 273.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x10.91.8 603.4%   
Avg P/E ratio x38.420.0 192.2%  
P/CF ratio (eoy) x34.014.6 233.1%  
Price / Book Value ratio x8.25.1 160.9%  
Dividend payout %26.82.2 1,220.8%   
Avg Mkt Cap Rs m761,5178,832 8,622.6%   
No. of employees `000NANA-   
Total wages/salary Rs m8,258662 1,247.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m69,6944,877 1,429.0%  
Other income Rs m62737 1,678.8%   
Total revenues Rs m70,3214,914 1,430.9%   
Gross profit Rs m28,611839 3,409.3%  
Depreciation Rs m2,556163 1,567.3%   
Interest Rs m21136 15.4%   
Profit before tax Rs m26,660577 4,619.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,818135 5,057.5%   
Profit after tax Rs m19,843442 4,486.1%  
Gross profit margin %41.117.2 238.6%  
Effective tax rate %25.623.4 109.5%   
Net profit margin %28.59.1 313.9%  
BALANCE SHEET DATA
Current assets Rs m67,9063,168 2,143.7%   
Current liabilities Rs m17,2842,198 786.2%   
Net working cap to sales %72.619.9 365.5%  
Current ratio x3.91.4 272.7%  
Inventory Days Days1014 70.3%  
Debtors Days Days878932 94.2%  
Net fixed assets Rs m45,9631,315 3,495.9%   
Share capital Rs m53197 547.6%   
"Free" reserves Rs m92,4151,637 5,644.0%   
Net worth Rs m92,9461,734 5,359.1%   
Long term debt Rs m0354 0.0%   
Total assets Rs m113,8694,482 2,540.3%  
Interest coverage x1,270.55.2 24,278.2%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.61.1 56.3%   
Return on assets %17.412.9 135.1%  
Return on equity %21.325.5 83.7%  
Return on capital %28.734.2 84.0%  
Exports to sales %011.5 0.0%   
Imports to sales %022.5 0.0%   
Exports (fob) Rs mNA561 0.0%   
Imports (cif) Rs mNA1,097 0.0%   
Fx inflow Rs m0561 0.0%   
Fx outflow Rs m01,097 0.0%   
Net fx Rs m0-536 0.0%   
CASH FLOW
From Operations Rs m19,469891 2,186.0%  
From Investments Rs m751-85 -883.2%  
From Financial Activity Rs m-349-786 44.4%  
Net Cashflow Rs m19,87219 102,431.4%  

Share Holding

Indian Promoters % 52.0 75.5 68.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.1 3.7 1,015.3%  
FIIs % 20.7 1.5 1,361.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 24.5 196.0%  
Shareholders   223,403 35,135 635.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   GENNEX LAB.  GSK PHARMA  BIOFIL CHEMICALS  LUPIN  GLENMARK PHARMA  



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

GUFIC BIOSCIENCE 2020-21 Annual Report Analysis (Annual Result Update)

Nov 1, 2021 | Updated on Nov 1, 2021

Here's an analysis of the annual report of GUFIC BIOSCIENCE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GUFIC BIOSCIENCE. Also includes updates on the valuation of GUFIC BIOSCIENCE.

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Dec 3, 2021 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 5-YR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS